The urinary excretion of estrogens following administration of female sex hormones has been compared with the relief obtained from hot flushes and other phenomena accompanying the menopause (1) and has been studied with regard to the percentage of the administered material which appears in the urine (3 to 12 per cent) (2) . Studies of the excretion of urinary androgens following the treatment of patients with testosterone propionate are reported below with regard to (a) the rapidity of the appearance and comparative levels of excretion in oral and intramuscular treatment, (b) the percentage of recovery in the urine of admninistered material, and (c) the evaluation of urinary levels of androgens as criteria of effective levels of male hormone in the body.
METHODS, MATERIALS, AND SUBJECTS
All urine samples were collected on a 24-hour basis and extracted with benzene in a continuous extractor according to the method previously described (3) . The assays for androgenic activity contained in the urine extracts were performed on the day-old chick's comb (4) . A minimum of 15 and usually 20 chicks were used for each assay. The accuracy of the determinations is considered to be ± 25 per cent and probably greater as can be calculated from previous data (4) . All (8, 9) , presence of vasomotor phenomena such as may be found in women at the menopause, skin pallor, and inability to tan (10) . Before androgenic administration, the level of output of male hormone in 4 urine assays covering 7 days, taken from a period of weeks, showed a daily average of 13.5 I.U. This is far below the levels of androgen excretion of normal adult men (11, 12, 3) . Still further evidence that if any abdominal testis were present it did not secrete large amounts of androgens was the negative clinical response obtained with 16 injections of large amounts of anterior pituitary-like substance, 100 rat units (R.U.) given three times weekly.
Case 2 is a 27-year-old sexually underdeveloped man, described in detail elsewhere (8) , who exhibited a like condition save that the genitalia instead of undergoing atrophy had never developed. The testes did not respond to injections of 100 R.U. of anterior pituitarylike material given 3 times weekly for 9 weeks.
RESULTS
A. Intramuscular administration. Intramuscular injections of 20 mgm. of testosterone propionate were given daily to Case 1 for 30 successive days. The resultant increased excretion of urinary androgens is shown in Table I . The average daily output prior to injections was 13.5 I.U. By the 3d day of injection, the output was 50 I.U. at which time some of the clinical symptoms of androgen deficiency remained, particularly the vasomotor phenomena. This is perhaps correlated with the fact that the longer the period 67 of androgen injection the greater the suppression of pituitary hyperactivity (13) .
This high level of androgen excretion was maintained throughout the period of treatment, as shown by assays of 11 out of the 16 remaining days of injection. The average daily output of 12 days, ranging from the 3d to the 30th day was 68.9 I.U., an increase of 510 per cent. In all determinations this level remained within the range of 40 to 100 I.U. which is the range for normal men as determined by several groups of workers (11, 12, 3) . After the first few days castration symptoms remained absent throughout the course of treatment. Thus, with the intramuscular injections which maintained normal ranges of urinary androgens, the patient remained symptom-free.
Eight to 9 days after the cessation of injections, the daily output was still 38 I.U. Although this was an increase of 281 per cent over the castrate level and can hardly be considered lower than normal levels, castration signs were again of considerable severity.
Determinations done 30 and 37 days respectively after the end of treatment showed 13 I.U., a return to low pre-injection levels. The possibility that all of the testosterone propionate is converted into dehydroisoandrosterone is unlikely since, as shown in Table III, this would mean an excretion of more material than was administered.
There is no proof that the pre-treatment level of male hormone secretion by the body was maintained during the injection of the testosterone propionate, especially since this intramuscular administration of androgen greatly decreased the urinary level of gonadotropic (follicle-stimulating) substance in this patient (14) . If none of the excreted androgen were of endogenous origin, more of the amount excreted would be considered as recovered from the administered hormone. This would make estimates of the amount recovered as much as % higher.
DISCUSSION
Even if the figures for recovered hormone are no higher than listed, there remain the obvious facts that (1) daily intramuscular injections of 20 mgm. of testosterone propionate maintained excretion levels at approximately those determined for normal men and that castration symptoms disappeared during this treatment, and (2) orallyadministered crystalline testosterone propionate was readily absorbed from the gastro-intestinal tract and eliminated in large amounts through the kidneys; since, however, no satisfactory clinical relief was afforded even when absorption was continued during 16 hours of the day, it seems likely that the material was eliminated with great rapidity. The figures indicate that increasing the oral dose of crystalline testosterone propionate can be expected to result in only exceedingly brief levels of hormone in the fluids and tissues of the body. In the maintenance of effective levels in the body by oral means there must be a balance between slow absorption to avoid prompt elimination by the kidneys and ready absorption to prevent waste in the feces. Furthermore, damage (15, 16 ) from large doses of male hormone may be incurred, especially in the kidney and the vascular system.
The transient presence of orally-administered testosterone propionate within the body and the rapid appearance of large quantities of androgenic material in the urine raise the question of threshold levels. It may be that when a certain threshold is reached, the hormone above this level is excreted in the urine. In this connection it is interesting to note that in adrenal virilism in women, enormous titers of androgen activity in the urine may be observed, but the masculinization does not proceed beyond that of the normal male.
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